Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Aug 20;16(8):e0256260. doi: 10.1371/journal.pone.0256260

Association of neck circumference and hypertension among adults in a rural community Thailand: A cross-sectional study

Panuwat Soitong 1, Saowaluck Jangjaicharoen 1, Apisit Kaewsanit 1, Parinya Mali 1, Yada Viriyakhaikul 1, Supakarn Boonnumma 1, Suphat Tipmabutr 1, Paratakorn Chalermchuang 1, Warunporn Maneechot 1, Chanunchida Numnoi 1, Kitwiwat Phungmali 1, Thana Meksong 1, Benjapon Ponpadermyod 1, Wachara Jirachairattanasin 1, Boonsub Sakboonyarat 2, Ram Rangsin 2, Mathirut Mungthin 3, Phunlerd Piyaraj 4,*
Editor: Yan Li5
PMCID: PMC8378687  PMID: 34415934

Abstract

Introduction

Hypertension (HT) is a major non-communicable disease worldwide and a growing global public health problem. Although several studies have investigated the independent associations of neck circumference (NC) and hypertension, no such studies have been conducted among the Thai population.

Aim

This study aims to identify risk factors associated with hypertension, which may be used to predict HT among asymptomatic adults residing in a remote rural community in central Thailand.

Method

1,084 adults were included in this community-based cross-sectional study by a population-based total survey. The participants were included those who had been living in 6 villages in the rural community in the central area of Thailand. Anthropometric information, NC, body composition indexes such as waist circumference and blood pressure were measured. Logistic regression models were fitted to calculate the multi-variable adjusted prevalence and the association of NC with HT.

Result

The prevalence of HT among adults in the rural community was 27.7% (95% CI: 25.0–30.3). Of the 300 adults with HT, 164 participants (54.7%) were found within the unawareness HT category. We found that associated factors with HT were included larger neck circumference both continuous and categorical (≥ 37.5 in male, ≥ 32.5 in female), pre-existing diabetes mellitus, male, and higher body mass index.

Conclusion

Almost one-third of participants in the remote rural areas presented hypertension. NC was associated with HT independent from other risk factors. NC is a simple and useful anthropometric index to identify HT in rural Thai adults.

Introduction

Hypertension (HT) is a major non-communicable disease worldwide. Moreover, it is confirmed that HT also leads to cardiovascular complications and deaths [1]. High blood pressure is associated with atherosclerotic cardiovascular diseases (ASCVD) including stroke, ischemic heart disease, and peripheral vascular disease [2, 3]. The number of adults with elevated blood pressure (BP) rose from 594 million in 1975 to 1.13 billion in 2015; 258 million of whom were living in South Asian countries [4]. The previous report of the 5th Thai National Health Examination Survey (NHES V) conducted in 2014 reported that the overall prevalence of HT in Thailand was 25.6% and 23.9% in males and females, respectively. Almost half of adult Thais (44.7%) with HT were not even aware of their abnormal blood pressure [5]. Previous studies show that there are traditional and modifiable risk factors associated with HT including physical activities, smoking, alcohol consumption, stress, dietary behavior, and body mass index (BMI) [6]. Additionally, the recent studies reported that neck circumference (NC) was a simple anthropometric marker that correlated with free fatty acids, insulin resistance, very-low-density lipoprotein cholesterol (VLDL), and high BP level [7, 8]; moreover, another study recommended using NC as an additional screening tool for predicting cardiovascular risk [9].

However, in Thailand, when comparing access to health services in urban versus rural areas; there are more limitations for remote rural areas. Only limited information is available on factors potentially responsible for hypertension in remote rural communities. The required information is essential to focus on attenuating the problems. Improving awareness of hypertension and control will help to reduce any complications including metabolic syndrome and ASCVD. The objectives of this study were to determine HT and identify risk factors for HT among adults of a remote rural community in the central area of Thailand. Furthermore, we expect to find some valuable measurement of NC, which may be associated with hypertension in asymptomatic adults.

Materials and methods

Study design and population

This study was conducted in a rural community in the central area of Thailand, 180 km, from Bangkok Metropolitan: Phra Phloeng rural community in Sa Kaeo province. A cross-sectional study was performed in December 2016. A population-based total survey was used to collect the information from 3,700 participants. The participants were included those who had been living in 6 villages in Phrapleung. All of the participants were interviewed. Inclusion criteria were defined as adult people aged 20 years or more who resided in the community at the time the study was performed. Women who were pregnant more than 20 weeks or postpartum less than 6 weeks and those who were previously diagnosed with secondary hypertension were excluded.

The questionnaire was designed to record information from the participants, covered information on demographics, self-reported pre-existing comorbidities including diabetes mellitus (DM), dyslipidemia (DLP), smoking, alcohol consumption, physical activity based on the Global Physical Activity Questionnaire as recommended by WHO that recommend physical activity achieving at least 600 MET-minutes. DM and DLP were the patient’s comorbidities that were previously diagnosed by a health care professional or used those medications. Ex-smoking and Ex-drinker were defined as smoke-free and alcohol-free for 12 months. Non-smoker and Non- drinkers were patients who have never smoked and drunk alcohol in his or her lifetime.

1,084 adults were included in the study. The participants were recruited by having the researcher team visit their homes by door-knocking. The face-to-face interviews using standard questionnaires were used to obtain information from the participants.

Clinical and laboratory parameters

Measurements were made using a standardized protocol. Bodyweight was determined without shoes and lightly clothed using an automatic electronic scale to the nearest 100 g. Height was measured without shoes to the nearest 0.5 centimeters. Waist circumference (WC) was measured after full expiration by using tape mid-way between the lowest rib and the top of the iliac crest. To measure NC, the participants were asked to extend their heads slightly and placed tape around the neck at the level of the Thyroid bone. Measure to be attached to the waist and neck fit, not too loose or too tight, and parallel with the ground. NC was categorized into two groups, i.e., normal (<37.5 cm in men) and <32.5 cm in women) and obesity (≥37.5 cm in men and ≥32.5 in women) [10]. BMI was calculated as body weight in kilogram divided by height in meters squared (m2) according to the criteria of the World Health Organization (WHO). We categorize the BMI as the WHO recommended cut-points for BMI categories in Asian populations as follows: 23–24.9 kg/m2, and ≥25 kg/m2 for overweight and obese [11]. The abdominal obesity as WC ≥ 90 cm for men and ≥ 80 cm for men women, according to the WHO-modified definitions for Asians [12].

HT was defined by The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and treatment of High Blood Pressure (JNC’s seventh hypertension guidelines) as high BP (SBP≥140mmHg or DBP≥90mmHg) and/or use of antihypertensive medication [13]. BP measurements were performed using mercury sphygmomanometers. The operators were trained in the standardized technique. Participants were advised to sit quietly for at least five minutes in a chair, with feet on the floor and arms supported at heart level. Patients avoided caffeine, smoking, and exercise for at least 30 minutes before being measured. At least two measurements were made, and the average was recorded. Unawareness of HT was defined as not having self-reported any prior diagnosis of HT by a health care professional among the participants defined as having HT [14]. Treatment of HT was defined as using an antihypertensive drug prescribed by a healthcare professional.

Statistical analysis

Data analyses were done using SPSS Statistics 22.0 and STATA/SE ver.11.0 program. We use descriptive statistical analysis to describe the prevalence, percentage, mean and SD, and analytic statistical analysis for associated factors by using univariate analysis with logistic regression analysis to determine the relationship between the exposures and outcome (hypertension) by presenting the magnitude of association with Crude odds ratio, at the 95% confidence intervals and p-value <0.05. Then, analyzing risk factors by controlling the potential confounding factors by multivariate analysis using multiple logistic regression analysis and presenting the relationship with Adjusted odds ratio. Confidence intervals, at the 95% level, were also reported for each adjusted odds ratio and p-value <0.05.

This study was approved by the Ethical Committee of the Royal Thai Army, Medical Department (approval number: 2559/67). The written informed consents were obtained from all participants in agreement with the WMA Declaration of Helsinki–Ethical principles for medical research involving human subjects.

Results

General characteristic of participants

The data was collected from the participants by using face-to-face interviews in December 2016. Table 1. Illustrates the demographic characteristics of participants. In total, there were 1,084 participants, 435 (40.1%) comprised males and 649 (59.9%) were females. Most of the participants were 50–59 years (28.7%). The average age of the population studied was 54.5 ± 13.1 years (range 20 to 97). The average NC of all participants was 34.5 ± 2.7 cm. The prevalence of HT among adults in a rural community was 27.7% (95% CI: 25.0–30.3). Of the 300 adults with HT, 66 participants (22%) were treated for HT while 164 participants (54.7%) were found within the unawareness HT category. To compare males and females, the prevalence of HT was 31.5% and 25.1%, respectively.

Table 1. General characteristics of participants enrolled into the study.

Characteristics Non-hypertension Hypertension Total (n = 1,084)
n (%) n (%) n (%)
Gender
 Male 298 (68.5) 137 (31.5) 435 (40.1)
 Female 486 (74.9) 163 (25.1) 649 (59.9)
Age (years) (mean ± SD) 53.8 ± 13.4 56.5 ± 12.2 54.5 ± 13.1
Age (years)
 20–29 29 (85.3) 5(14.7) 34 (3.1)
 30–39 72 (76.6) 22 (23.4) 94 (8.7)
 40–49 207 (78.4) 57 (21.6) 264 (24.4)
 50–59 219 (70.4) 92 (29.6) 311 (28.7)
 60–69 155 (65.7) 81 (34.3) 236 (21.9)
 70–79 82 (71.3) 33 (28.7) 115 (10.6)
 ≥80 20 (66.7) 10 (33.3) 30 (2.8)
Education level
 Illiterate 97 (76.4) 30 (23.6) 127 (11.7)
 Primary school 84 (73.7) 30 (26.3) 114 (10.5)
 Secondary school 581 (71.5) 232 (28.5) 813 (75)
 University 22 (73.3) 8 (26.7) 30 (2.8)
Occupations
 Agriculture 405 (68.4) 187 (31.6) 592 (54.6)
 Unemployed 112 (70.9) 46 (29.1) 158 (14.6)
 Employee 50 (76.9) 15 (23.1) 65 (6)
 Merchant 23 (65.7) 12 (34.3) 35 (3.2)
 Officer 12 (92.3) 1 (7.7) 13 (1.2)
 Others 182 (82.4) 39 (17.6) 221 (20.4)
Smoking
 Non-smoker 541 (74.5) 185 (25.5) 726 (67.0)
 Ex-smoker 101 (67.8) 48 (32.2) 149 (13.7)
 Smoker 142 (67.9) 67 (32.1) 209 (19.3)
Alcohol drinking
 Non-drinker 392 (73.5) 141 (26.5) 533 (49.2)
 Ex-drinker 156 (71.9) 61 (28.1) 217 (20.0)
 Alcoholic 236 (70.7) 98 (29.3) 334 (30.8)
BMI (kg/m 2 ) (mean ± SD) 23.8 ± 3.9 25.3 ± 4.4 24.2 ± 4.1
BMI (kg/m 2 )
 <18.5 52 (74.3) 18 (25.7) 70 (6.5)
 18.5–22.99 310 (80.7) 74 (19.3) 384 (35.4)
 23–24.99 167 (71.7) 66 (28.3) 233 (21.7)
 25–29.99 202 (67.1) 99 (32.9) 301 (27.8)
 ≥ 30 53 (55.2) 43 (44.8) 96 (8.9)
Waist circumference (cm) (mean ± SD) 83.3 ± 9.5 87.7 ± 10.9 84.5 ± 10.1
Waist circumference (cm)
 Normal (< 90 in male, < 80 in female) 402 (78.2) 112 (21.8) 514 (47.4)
 Obesity (≥ 90 in male, ≥ 80 in female) 382 (67) 188 (33) 570 (52.6)
Neck circumference (cm) (mean ± SD) 34.3 ± 2.4 35.2 ± 3.2 34.5 ± 2.7
Neck circumference (cm)
 < 37.5 in male, < 32.5 in female 388 (75.8) 124 (24.2) 512 (47.2)
 ≥ 37.5 in male, ≥ 32.5 in female 396 (69.20) 176 (30.8) 572 (52.8)
Comorbidities
 Pre-existing diabetes mellitus 55 (53.9) 47 (46.1) 102 (9.41)
 Pre-existing dyslipidemia 74 (54.4) 62 (45.6) 136 (12.55)

Factors associated with hypertension

Table 2 illustrates univariate analysis for factors associated with HT. We found that females, old age (≥ 60 years old), BMI, WC, NC, occupation (agriculture, merchant, and unemployed), pre-existing diabetes mellitus, and pre-existing dyslipidemia were correlated with HT. Table 3 illustrate the models of multivariate analysis for factors associated with HT stratified by gender for the continuous and categorical variables of NC (continuous (model A) and categorical (model B). We found that NC both continuous and categorical variables are strongly significant with HT in all models.

Table 2. Univariate logistic regression analysis to assess relationships between associated risk factor and hypertension in the rural communities in Thailand.

Crude Odds ratio 95% CI* p-value
Gender
 Male 1.00
 Female 0.73 0.56–0.96 0.022
Age (10 years) 1.17 1.06–1.29 0.003
Age
 20–39 1.00
 40–59 1.31 0.83–2.10 0.256
 ≥ 60 years old 1.81 1.12–2.90 0.015
Body Mass Index (kg/m 2 )
 <23 1.00
 23–24.99 1.56 1.08–2.24 0.018
 25–29.99 1.93 1.38–2.69 <0.001
 ≥30 3.19 2.01–5.07 <0.001
Body Mass Index (kg/m2) (continuous variable) 1.09 1.06–1.12 <0.001
Waist circumference (cm)
 Normal (< 90 in male, < 80 in female) 1.00
 obesity (≥ 90 in male, ≥ 80 in female) 1.77 1.35–2.32 <0.001
Waist circumference (cm) (continuous variable) 1.05 1.03–1.06 <0.001
Neck circumference (cm)
 < 37.5 in male, < 32.5 in female 1.00
 ≥ 37.5 in male, ≥ 32.5 in female 1.39 1.06–1.82 0.020
Neck circumference (cm) (continuous variable) 1.11 1.05–1.16 <0.001
Occupation
 Others 1.00
 Agriculture 2.16 1.46–3.17 <0.001
 Employee 1.40 0.71–2.74 0.327
 Merchant 2.44 1.12–5.31 0.025
 Officer 0.39 0.05–3.08 0.371
 Unemployed 1.98 1.18–3.12 0.009
Smoking
 Non-smoker 1.00
 Ex-smoker 1.39 0.95–2.04 0.091
 Smoker 1.38 0.99–1.93 0.060
Alcohol drinking
 Non-drinker 1.00
 Ex-drinker 1.09 0.76–1.55 0.643
 Alcoholic 1.15 0.85–1.57 0.355
Pre-existing diabetes mellitus 2.18 1.44–3.32 <0.001
Pre-existing dyslipidemia 2.22 1.53–3.23 <0.001
Activity
 Not recommend (< 600 MET**-minutes per week) 1.00
 Recommend (≥ 600 MET-minutes per week) 0.85 0.64–1.14 0.279
Family history of hypertension 1.25 0.89–1.75 0.193

*CI: Confidence Interval;

**MET: Metabolic Equivalent.

Table 3. Multivariate logistic regression analysis to assess relationships between associated risk factor and hypertension stratify by gender (male, female and total).

Male Female All
Model A: Neck circumference as continuous variable aOR* 95%CI** p-value aOR* 95%CI** p-value aOR* 95%CI** p-value
Model A1
 Neck circumference (cm) 1.12 1.03–1.21 0.007 1.10 1.02–1.19 0.011 1.11 1.05–1.18 <0.001
 Female 1.08 0.75–1.55 0.674
Model A2
 Neck circumference (cm) 1.13 1.04–1.23 0.004 1.10 1.03–1.20 0.009 1.12 1.06–1.19 <0.001
 Female 1.13 0.79–1.62 0.784
 Age (10 years) 1.01 0.99–1.03 0.152 1.02 1.00–1.03 0.030 1.02 1.00–1.03 0.011
Model A3
 Neck circumference (cm) 1.12 1.02–1.22 0.011 1.10 1.02–1.19 0.014 1.11 1.05–1.18 <0.001
 Female 1.05 0.73–1.52 0.728
 Age (10 years) 1.01 0.99–1.03 0.424 1.01 0.99–1.03 0.076 1.01 0.99–1.02 0.060
 Pre-existing diabetes mellitus 2.81 1.24–6.38 0.013 1.99 1.00–3.11 0.047 2.06 1.30–3.27 0.002
Model A4
 Neck circumference (cm) 1.12 1.03–1.22 0.010 1.09 1.01–1.18 0.020 1.10 1.04–1.71 0.001
 Female 1.01 0.69–1.46 0.957
 Age (10 years) 1.01 0.99–1.03 0.405 1.01 0.99–1.02 0.164 1.01 0.99–1.02 0.105
 Pre-existing diabetes mellitus 2.95 1.22–7.13 0.016 1.35 0.73–2.50 0.334 1.76 1.07–2.89 0.026
 Pre-existing dyslipidemia 0.88 0.34–2.00 0.757 1.84 1.07–3.17 0.026 1.46 0.93–2.29 0.096
Model A5
 Neck circumference (cm) 1.12 1.03–1.22 0.009 1.09 1.01–1.18 0.020 1.10 1.04–1.71 0.001
 Female 1.01 0.69–1.46 0.967
 Age (10 years) 1.01 0.99–1.03 0.318 1.01 0.99–1.03 0.162 1.01 0.99–1.02 0.091
 Pre-existing diabetes mellitus 3.01 1.24–7.31 0.015 1.35 0.73–2.51 0.335 1.76 1.07–2.89 0.027
 Pre-existing dyslipidemia 0.83 0.36–1.91 0.659 1.84 1.07–3.17 0.026 1.44 0.99–2.27 0.106
 Waist circumference (cm) 0.99 0.97–1.00 0.174 0.99 0.98–1.01 0.868 0.99 0.98–1.00 0.325
Model A6
 Neck circumference (cm) 1.13 1.04–1.24 0.006 1.10 0.01–1.19 0.023 1.11 1.05–1.78 0.001
 Female 0.96 0.66–1.41 0.857
 Age (10 years) 1.01 0.99–1.03 0.193 1.01 0.99–1.03 0.298 1.01 0.99–1.02 0.099
 Pre-existing diabetes mellitus 2.72 1.13–6.61 0.026 1.47 0.79–2.77 0.220 1.83 1.10–3.03 0.019
 Pre-existing dyslipidemia 0.81 0.35–1.86 0.621 1.86 1.07–3.22 0.026 1.43 0.91–2.25 0.123
 Body Mass Index (kg/m2) 0.99 0.98–1.01 0.549 0.99 0.98–1.02 0.961 0.99 0.98–1.00 0.590
Model B: Neck circumference as categorical variable
Model B1
 Neck circumference (cm)
  <37.5 in male, < 32.5 in female 1.00 1.00 1.00
  ≥ 37.5 in male, ≥32.5 in female 2.90 1.74–4.83 <0.001 1.95 1.23–3.09 0.004 2.34 1.65–3.31 <0.001
 Female 0.59 0.42–0.83 0.003
Model B2
 Neck circumference (cm)
  <37.5 in male, < 32.5 in female 1.00 1.00 1.00
  ≥ 37.5 in male, ≥32.5 in female 3.07 1.82–5.19 <0.001 1.99 1.25–3.16 0.003 2.42 1.70–3.44 <0.001
 Female 0.59 0.42–0.84 0.003
 Age (10 years) 1.01 0.99–1.03 0.114 1.02 1.00–1.03 0.051 1.01 1.00–1.03 0.015
Model B3
 Neck circumference (cm)
  <37.5 in male, < 32.5 in female 1.00 1.00 1.00
  ≥ 37.5 in male, ≥32.5 in female 2.72 1.59–4.66 <0.001 1.91 1.20–3.05 0.006 2.27 1.59–3.23 <0.001
 Female 0.58 0.41–0.83 0.003
 Age (10 years) 1.01 0.99–1.03 0.333 1.01 0.99–1.03 0.096 1.01 0.99–1.02 0.060
 Pre-existing diabetes mellitus 2.53 1.12–5.74 0.026 1.54 0.89–2.67 0.120 1.81 1.15–2.84 0.010
Model B4
 Neck circumference (cm)
  <37.5 in male, < 32.5 in female 1.00 1.00 1.00
  ≥ 37.5 in male, ≥32.5 in female 2.71 1.58–4.64 <0.001 1.82 1.14–2.91 0.012 2.20 1.54–3.14 <0.001
 Female 0.57 0.40–0.81 0.002
 Age (10 years) 1.01 0.98–1.03 0.347 1.01 0.99–1.03 0.212 1.01 0.99–1.02 0.115
 Pre-existing diabetes mellitus 2.44 1.02–5.84 0.046 1.18 0.65–2.16 0.584 1.51 0.93–2.46 0.098
 Pre-existing dyslipidemia 1.10 0.49–2.47 0.809 1.83 1.07–3.14 0.027 1.54 0.99–2.41 0.055
Model B5
 Neck circumference (cm)
  <37.5 in male, < 32.5 in female 1.00 1.00 1.00
  ≥ 37.5 in male, ≥32.5 in female 1.95 1.02–3.74 0.042 1.86 1.12–3.10 0.017 1.93 1.30–2.89 0.001
 Female 0.57 0.40–0.82 0.002
 Age (10 years) 1.01 0.98–1.03 0.161 1.01 0.99–1.02 0.331 1.01 0.99–1.02 0.095
 Pre-existing diabetes mellitus 2.33 0.91–5.94 0.077 1.48 0.79–2.75 0.219 1.71 1.02–2.85 0.040
 Pre-existing dyslipidemia 0.97 0.42–2.23 0.950 1.64 0.94–2.86 0.080 1.38 0.87–2.19 0.165
 Waist circumference (cm)
  Normal (< 90 in male, < 80 in female) 1.00 1.00 1.00
  obesity (≥ 90 in male, ≥ 80 in female) 1.10 0.93–1.34 0.346 1.17 0.85–1.39 0.470 1.12 0.90–1.23 0.305
Model B6
 Neck circumference (cm)
  <37.5 in male, < 32.5 in female 1.00 1.00 1.00
  ≥ 37.5 in male, ≥32.5 in female 2.01 1.10–4.12 0.038 1.82 1.12–3.10 0.017 1.76 1.14–2.70 0.010
 Female 0.55 0.38–0.79 0.001
 Age (10 years) 1.01 0.99–1.03 0.257 1.01 0.99–1.03 0.292 1.01 0.99–1.02 0.090
 Pre-existing diabetes mellitus 3.11 1.18–8.15 0.021 1.41 0.75–2.63 0.284 1.86 1.01–3.10 0.018
 Pre-existing dyslipidemia 0.95 0.40–2.21 0.899 1.72 0.98–3.00 0.057 1.37 0.87–2.17 0.176
 Body Mass Index (kg/m2)
  <23 1.00 1.00 1.00
  23–24.99 3.15 0.76–8.18 0.318 1.43 0.48–4.28 0.524 2.25 1.12–4.52 0.022
  25–29.99 1.78 0.84–3.79 0.131 1.45 0.75–2.79 0.268 1.55 0.95–2.55 0.080
  ≥30 3.54 1.64–7.62 0.001 1.31 0.75–2.31 0.343 1.89 1.20–2.98 0.006

*aOR: adjusted odds ratio;

**CI: Confidence Interval;

Multivariate logistic regression analysis, Backward Wald method (Model A: neck circumference as continuous variable and Model B: neck circumference as categorical variable)

In model A, NC as the continuous variable was used in the analysis. After adjusting for neck circumference (continuous variable), gender, age, pre-existing diabetes mellitus, and pre-existing dyslipidemia (model A4), the adjusted odds ratio (aOR) along with the 95% confidence interval (95%CI) of association between NC and HT was 1.10 (1.04–1.71). Further, the WC or BMI was added for adjusting in models A5 (WC) and A6 (BMI), we found that NC and pre-existing diabetes mellitus were statistically significantly associated with HT. The aOR and 95%CI of NC and pre-existing diabetes mellitus in model 5 and model 6 were 1.10 (1.04–1.11), 1.76 (1.07–2.89), 1.11 (1.05–1.78), and 1.83 (1.10–3.03), respectively. In addition, sub-analysis stratified by gender was performed. Among male participants, NC and pre-existing diabetes mellitus were associated with HT and among female participants, NC and pre-existing dyslipidemia were associated with HT in model A4-6.

In model B, NC as the categorical variable was used in the analysis. After adjusting for neck circumference (categorical variable), gender, age, pre-existing diabetes mellitus, and pre-existing dyslipidemia (model B4), the adjusted odds ratio (aOR) along with the 95% confidence interval (95%CI) of association between NC (≥ 37.5 in males, ≥32.5 in females) and HT was 2.20 (1.53–3.14). Same as model A, the WC or BMI was added for adjusting in models B5 (WC) and B6 (BMI). We found that the factors associated with HT were include NC (aOR = 1.93 (1.30–2.89)), female (aOR = 0.57 (0.40–0.82)), and pre-existing diabetes mellitus (aOR = 1.71 (1.02–2.85)) in model B5 (WC) and NC (aOR = 1.76 (1.14–2.70)), female (aOR = 0.55 (0.38–0.79)), pre-existing diabetes mellitus (aOR = 1.86 (1.01–3.10)), BMI: 23–24.9 kg/m2 (aOR = 2.25 (1.12–4.52)), and BMI ≥ 30 kg/m2 (aOR = 1.89 (1.20–2.98)) in model B6 (BMI). Although Neck circumference is related to hypertension in all models regardless of adjusting WC or BMI, the correlation between higher neck circumference (≥ 37.5 cm. in male, ≥32.5 cm. in female) and HT tended to decrease after adjusting WC or BMI. Sub-analysis stratified by gender also performed in model B and NC was associated with HT in all models. In addition, pre-existing diabetes mellitus and BMI ≥30 kg/m2 were associated with HT among male participants (model B6).

Discussion

The study aimed to determine the prevalence and associated factors of HT in a Thai remote rural community, especially higher neck circumference. The prevalence of HT in this study was 27.7%. To compare with the prevalence of HT in NHES V in 2014 [5], the results in the present study are relatively high. One potential explanation for this higher percentage is in this area, working-age adults were working temporarily in urban cities. Obviously, most of the population is older than 50 (63.8%). In addition, the Thai NHES V was conducted in urban and suburban areas, differing from the study in a remote rural community. We found that the prevalence of HT among adults in other rural areas in Asian countries differs from our finding in this study. Some countries like India [15] and Vietnam [6] indicated that the prevalence of HT was 25% and 20.8% respectively, while the studies in Myanmar [16] and China [17] show a higher prevalence of HT when compared with our report. The latest previous study of a Thai rural area in 2006 [18] reported that the prevalence of HT among adults in rural areas was 18.0%, which was lower than our findings. It might be because of a change of dietary habits, economic development, and lifestyle to be more urban.

Furthermore, we found that 54.7% of adults with HT were unaware of their high blood pressure. Similar to the other studies reported in Asia, the unawareness of HT was also higher than 50% among people at risk [19]. Compared to the unawareness HT in Thai NHES V [5] of 44.7%, the findings in this remote rural community were relatively high. This phenomenon can be explained by the difference of context in the area. Firstly, in the rural community, the people may have difficultly accessing the health care system; moreover, the people may have not enough health literacy, especially for HT [20]. Additionally, the low socioeconomic status in rural areas may also explain this situation [21].

Our study found that higher neck circumference, gender, and pre-existing diabetes mellitus are associated with HT. The prevalence of HT in females is lower than that in males. There were several studies [22, 23] reported that females tend to have lower rates of HT than males. However, the postmenopausal stage in which estrogen is depleted plays a major role in vasodilation resulting in increased blood pressure in elderly females [24]. Moreover, the previous study of Everett B et al. showed that females may be more aware of their diseases and therefore more likely to access the health care service when compared with males [22]. Furthermore, there are differences in RAS system receptors in gender which affect blood pressure. As angiotensin II type 2 receptor (AT2) has a role in cardioprotective effect, in general, there are more AT2 expressions in females than those in males, resulting from sex chromosome complement and estrogen [25].

In our study, the participants who have high neck circumference both continuous and categorical (≥ 37.5 in males, ≥ 32.5 in females) variables were more likely to have HT. Similar to a related study in the US, the Framingham Heart Study, which followed 2,732 peoples for 10 years (1995–2008) reported that higher neck circumference was associated with HT and all cardiometabolic risk factors [7]. A recent study in Thailand showed that high neck circumference was associated with an increase of blood pressure resulting in uncontrolled HT [8] The phenomenon can be explained by a significant correlation between NC and a pathogenic fatty deposit [7]. Moreover, the previous study by Koutsari et al. [26] described that upper–body obesity provides excessive adipose tissue lipolysis which leads to high oxidative stress, stimulates endothelial cell dysfunction and vascular injury, resulting in increased blood pressure. Additionally, the previous studies found that NC was related to obstructive sleep apnea (OSA), which was significantly associated with HT [27]. The mechanisms that influenced the increased risk for HT in OSA patients were pro-inflammatory effect, increased oxidative stress, and increase vascular stiffness.

WC and BMI are obviously used as a measure of obesity and risk assessment for CVD risk in clinical guidelines. Furthermore, several studies were found that waist circumference is significantly associated with increased blood pressure [28]. Although prior studies report that the cardio-metabolic risk can be predicted by WC and waist-to-hip ratio (WHR) [29], measuring is difficult due to the position to measure, fullness and clothing [30]. NC measurement is convenient; moreover, the measurement is constant and time-saving. The previous study [31] examined the association between NC and HT. It found that NC was strongly associated with HT, and the association became less magnitude of association after adjusting for BMI or NC. Moreover, the recent study suggests that the sensitivity, specificity, positive and negative predictive values of NC are better than WC in the marker of excessive fat tissue deposition which correlated with HT risk factors [32].

DM and HT usually co-exist in the patient. However, it is difficult to tell distinctly the mechanisms of DM that cause hypertension and mechanisms of hypertension that lead to DM because they are so similar, and it is difficult to clarify the initiative of each mechanism. DM can be the cause of hypertension due to several mechanisms including hyperinsulinemia, hyperglycemic crisis, and vascular dysfunction [33]. Hyperinsulinemia may lead to vascular injury and promote the vascular remodeling process resulting in vascular dysfunction [34]. Likewise, in hyperglycemia and hyperglycemic crisis, there are oxidative stress and inflammation which lead to cellular and endothelial dysfunction [34].

Limitation of the study

One of the limitations of our study was it could not determine a temporal relationship because the study employed a cross-sectional design. Even though our study used standard measurement of HT, the masked HT may have resulted from the prevalence of HT in the study. Our study cannot be generalized to the whole country but may reflect challenges to patients residing in rural communities of Thailand. All exposures were self-reported and did not include blood biochemical data. Therefore, there might cause a recall bias. Nevertheless, this study used face-to-face interviews. So, this bias might also exist in this study. Due to the unavailable of data, we cannot investigate the effect of the anti-hypertensive drug on the relationship between NC and hypertension. We suggest the further study should take this issue into account by making an adjustment or analysis in a separate population of untreated and treated with the anti-hypertensive drug. The last limitation was that more than one-half of the participants were elderly working-age people immigrating to urban areas, causing the prevalence of high BP to be higher than it normally should be.

Conclusions

In conclusion, almost one-third of participants in the remote rural community presented HT, and one-half of adults with HT were unaware of their condition. We identified potential risk factors for HT including being male, pre-exciting DM, especially and NC. The findings from this study confirmed that NC was associated with HT independent from other risk factors. Effective public health interventions including weight management, glycemic control, and suitable lipid profile should be provided to people in the rural community. Eventually, education concerning HT and its complications should be implemented in rural communities to attenuate HT and cardiovascular sequelae.

Data Availability

All relevant data are within the paper.

Funding Statement

This study was supported by Department of Military and Community Medicine, Phramongkutklao College of Medicine for financial contribution to the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Who A. Global brief on hypertension. World Health Organization. 2013.
  • 2.Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. Jama. 1996;275(20):1557–62. [PubMed] [Google Scholar]
  • 3.Dickinson CJ. Strokes and their relationship to hypertension. Curr Opin Nephrol Hypertens. 2003;12(1):91–6. doi: 10.1097/00041552-200301000-00015 [DOI] [PubMed] [Google Scholar]
  • 4.Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet (London, England). 2017;389(10064):37–55. doi: 10.1016/S0140-6736(16)31919-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Institute HSR. Thai National Health Examination V (NHES V) 2014 [cited 2019 May 1]. https://www.hsri.or.th/researcher/research/new-release/detail/7711.
  • 6.Do HT, Geleijnse JM, Le MB, Kok FJ, Feskens EJ. National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults. American journal of hypertension. 2014;28(1):89–97. doi: 10.1093/ajh/hpu092 [DOI] [PubMed] [Google Scholar]
  • 7.Preis SR, Massaro JM, Hoffmann U, D’Agostino RB Sr, Levy D, Robins SJ, et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. The journal of clinical endocrinology & metabolism. 2010;95(8):3701–10. doi: 10.1210/jc.2009-1779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Meelab S, Bunupuradah I, Suttiruang J, Sakulrojanawong S, Thongkua N, Chantawiboonchai C, et al. Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand: A cross-sectional study. PloS one. 2019;14(2):e0212572. doi: 10.1371/journal.pone.0212572 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zanuncio VV, Pessoa MC, Pereira PF, Longo GZ. Neck circumference, cardiometabolic risk, and Framingham risk score: Population-based study. Revista de Nutrição. 2017;30(6):771–81. [Google Scholar]
  • 10.Alzeidan R, Fayed A, Hersi AS, Elmorshedy H. Performance of neck circumference to predict obesity and metabolic syndrome among adult Saudis: a cross-sectional study. BMC obesity. 2019;6:13. doi: 10.1186/s40608-019-0235-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid A, et al. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd. 2000. [Google Scholar]
  • 12.Organization WH. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. 2011.
  • 13.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 2003;289(19):2560–72. doi: 10.1001/jama.289.19.2560 [DOI] [PubMed] [Google Scholar]
  • 14.Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40(6):920–7. doi: 10.1161/01.hyp.0000040263.94619.d5 [DOI] [PubMed] [Google Scholar]
  • 15.Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. Journal of hypertension. 2014;32(6):1170. doi: 10.1097/HJH.0000000000000146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Htet AS, Bjertness MB, Oo WM, Kjøllesdal MK, Sherpa LY, Zaw KK, et al. Changes in prevalence, awareness, treatment and control of hypertension from 2004 to 2014 among 25-74-year-old citizens in the Yangon Region, Myanmar. BMC public health. 2017;17(1):847. doi: 10.1186/s12889-017-4870-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Li J, Shi L, Li S, Xu L, Qin W, Wang H. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese Adults from 1993 to 2011. International journal for equity in health. 2017;16(1):50. doi: 10.1186/s12939-017-0545-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Howteerakul N, Suwannapong N, Sittilerd R, Rawdaree P. Health risk behaviours, awareness, treatment and control of hypertension among rural community people in Thailand. Asia-Pacific journal of public health. 2006;18(1):3–9. doi: 10.1177/10105395060180010201 [DOI] [PubMed] [Google Scholar]
  • 19.Son P, Quang N, Viet N, Khai P, Wall S, Weinehall L, et al. Prevalence, awareness, treatment and control of hypertension in Vietnam—results from a national survey. Journal of human hypertension. 2012;26(4):268. doi: 10.1038/jhh.2011.18 [DOI] [PubMed] [Google Scholar]
  • 20.Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. Journal of hypertension. 2016;34(1):39–46. doi: 10.1097/HJH.0000000000000745 [DOI] [PubMed] [Google Scholar]
  • 21.Grotto I, Huerta M, Sharabi Y. Hypertension and socioeconomic status. Curr Opin Cardiol. 2008;23(4):335–9. doi: 10.1097/HCO.0b013e3283021c70 [DOI] [PubMed] [Google Scholar]
  • 22.Everett B, Zajacova A. Gender differences in hypertension and hypertension awareness among young adults. Biodemography and social biology. 2015;61(1):1–17. doi: 10.1080/19485565.2014.929488 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ghosh S, Mukhopadhyay S, Barik A. Sex differences in the risk profile of hypertension: a cross-sectional study. BMJ open. 2016;6(7):e010085. doi: 10.1136/bmjopen-2015-010085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, et al. Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population. Journal of the American Heart Association. 2016;5(3):e003053. doi: 10.1161/JAHA.115.003053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gillis EE, Sullivan JC. Sex Differences in Hypertension: Recent Advances. Hypertension. 2016;68(6):1322–7. doi: 10.1161/HYPERTENSIONAHA.116.06602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Koutsari C, Jensen MD. Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. Journal of Lipid Research. 2006;47(8):1643–50. doi: 10.1194/jlr.R600011-JLR200 [DOI] [PubMed] [Google Scholar]
  • 27.Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D. Obstructive sleep apnea, hypertension and cardiovascular diseases. Journal of human hypertension. 2015;29(12):705. doi: 10.1038/jhh.2015.15 [DOI] [PubMed] [Google Scholar]
  • 28.Momin M, Fan F, Li J, Jia J, Zhang L, Zhang Y, et al. Joint Effects of Body Mass Index and Waist Circumference on the Incidence of Hypertension in a Community-Based Chinese Population. Obesity facts. 2020;13(2):245–55. doi: 10.1159/000506689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. European heart journal. 2007;28(7):850–6. doi: 10.1093/eurheartj/ehm026 [DOI] [PubMed] [Google Scholar]
  • 30.Namazi N, Larijani B, Surkan PJ, Azadbakht L. The association of neck circumference with risk of metabolic syndrome and its components in adults: A systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2018;28(7):657–74. doi: 10.1016/j.numecd.2018.03.006 [DOI] [PubMed] [Google Scholar]
  • 31.Liang J, Wang Y, Dou L, Li H, Liu X, Qiu Q, et al. Neck circumference and prehypertension: the cardiometabolic risk in Chinese study. 2015;33(2):275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Moradi S, Mohammadi H, Javaheri A, Ghavami A, Rouhani MH. Association between neck circumference and blood pressure: a systematic review and meta-analysis of observational studies. Hormone and metabolic research = Hormon-und Stoffwechselforschung = Hormones et metabolisme. 2019;51(8):495–502. doi: 10.1055/a-0957-3256 [DOI] [PubMed] [Google Scholar]
  • 33.Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Current atherosclerosis reports. 2012;14(2):160–6. doi: 10.1007/s11883-012-0227-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension: an update. Endocrinology and Metabolism Clinics. 2014;43(1):103–22. doi: 10.1016/j.ecl.2013.09.005 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES